Express Scripts通过十年改革和解了FTC胰岛素定价诉讼，以降低成本并结束不公平做法。 Express Scripts settles FTC insulin pricing lawsuit with 10-year reforms to lower costs and end unfair practices.

Cigna的药店福利经理Expressscripts已经解决了FTC对胰岛素定价的诉讼, Express Scripts, Cigna’s pharmacy benefit manager, has settled an FTC lawsuit over insulin pricing, agreeing to a 10-year deal that ends spread pricing, mandates transparency, and requires moving its Swiss-based GPO to the U.S. 这项和解避免了大型反断审判, 要求小型药店支付成本加偿, 包括为期三年的合规监督, 并允许TrumpRX购买计入合支付. The settlement, which avoids a major antitrust trial, mandates cost-plus reimbursement for small pharmacies, includes a three-year compliance monitorship, and allows TrumpRX purchases to count toward copays. 其目的是在十年内将药物费用降低70亿美元,并解决对价格上涨和不公平指导做法的关切。 It aims to lower drug costs by up to $7 billion over a decade and addresses concerns over inflated prices and unfair steering practices. 联邦贸易委员会称这是一项重大的监管转变,而行业监督者则欢迎改革,但敦促进一步审查特殊药物分类和伙伴关系。 The FTC calls it a major regulatory shift, while industry watchdogs welcome reforms but urge further scrutiny of specialty drug classification and partnerships.